NIPH Clinical Trials Search

UMIN ID: UMIN000001781

Registered date:18/03/2009

Refractory VT/VF, Prospective Evaluation to Differentiate Lidocaine Efficacy from Nifekalant

Basic Information

Recruitment status Complete: follow-up complete
Health condition(s) or Problem(s) studiedVentricular tachycardia, Ventricular fibrillation
Date of first enrollment2005/07/01
Target sample size55
Countries of recruitmentJapan
Study typeObservational


Primary OutcomeTermination of VT/VF with/without shock
Secondary OutcomeReturn of spontaneous circulation, One-month survival, Discharge alive from the hospital, Adverse events: asystole,pulseless electrical activity, Torsades de pointes, QT prolongation(>0.55)

Key inclusion & exclusion criteria

Age minimumNot applicable
Age maximumNot applicable
GenderMale and Female
Include criteria
Exclude criteriaDrug-induced long QT syndrome Congenital long QT syndrome

Related Information


public contact
Name Tsuyoshi Shiga
Address 8-1 Kawada-cho, Shinjuku-ku, Tokyo 162-8666, Japan Japan
Telephone 03-3353-8111
Affiliation Tokyo Women's Medical University Cardiology
scientific contact
Name Hiroshi Kasanuki
Address 1-7 Koji-machi, Chiyoda-ku, Tokyo 102-0083 Japan Japan
Telephone 03-5216-3001
Affiliation Waseda University Science and Engineering